Richard Ridinger resigns from CEO position at Lonza causing shares to plummet
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland
Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
Read Pharmafocus January/February 2019 edition online now!
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines
We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial
January 30, 2019Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases
Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …
Israeli biotech claims it has developed cure for cancer
January 30, 2019Research and Development Cancer, MuTaTo, biotech, israel, lung cancer, oncology
An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …
Roche pulls plug on Alzheimer’s drug after Phase 3 failure
January 30, 2019Research and Development AC Immune, Alzheimer's, Roche, crenezumab, pharma
Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …
ABPI warns of skills shortage in UK caused by lack of STEM grads and Brexit
January 30, 2019Research and Development ABPI, UK, eomployment, skills, stem, work
The UK is falling behind Europe and the rest of the world in regards to the number of students studying …
Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug
January 29, 2019Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids
Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …
Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia
January 29, 2019Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma
It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …
Precision cancer treatment for dogs moves towards human testing
January 29, 2019Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells
Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …
Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance
January 29, 2019Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma
UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …
Edinburgh researchers genetically modify chickens to produce medicine filled eggs
January 29, 2019Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins
Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
Alexander Hardy returns to Genentech as new CEO
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Philip Hampton to step down from chairman role at GSK
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Novartis warns of huge impact of no-deal Brexit
January 28, 2019Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma
Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
Head of opioid advisory panel criticises FDA for complacency in ongoing crisis
January 28, 2019Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma
The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
People in England will be able to pay the NHS to sequence their genetic data, if they share it with scientists
January 28, 2019Sales and Marketing Alzheimer's, Cancer, England, NHS, genetic data, genomes, health
The NHS will provide paid-for health reports, informing patients as to the likelihood that they will develop diseases such as …
Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court
January 28, 2019Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents
Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …
Top Ten most popular articles on Pharmafile.com this week!
January 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo
While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …
Bristol-Myers Squibb withdraws lung cancer combo therapy marketing application
January 25, 2019Medical Communications BMS, Merck, Yervoy, ctla4, lung cancer, opdivo
Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer. …
China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk
January 25, 2019Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke
Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
